The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line

Immunogenetics

Volumn 56, Issue 9, 2004, Pages 617-624

  Sala, Frédéric G ^a   Moral, Pierre Marie Del ^a   Pizzato, Nathalie ^a   Legrand Abravanel, Florence ^a   Le Bouteiller, Philippe ^a   Lenfant, Françoise ^a  

^a CHU PURPAN   (France)

Author keywords

HLA E; HLA G; Natural killer cell; Polymorphism; Pregnancy

Indexed keywords

CD94 ANTIGEN; CELL RECEPTOR; CHROMIUM 51; HLA E ANTIGEN; HLA G ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; UNCLASSIFIED DRUG; CHROMIUM; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA G*0105N ANTIGEN; HLA-E ANTIGEN; HLA-G*0105N ANTIGEN; IMMUNOGLOBULIN RECEPTOR; ISOPROTEIN; KLRD1 PROTEIN, HUMAN; LECTIN; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL ACTIVATING RECEPTORS;

ARTICLE; CANCER CELL CULTURE; CELL SURFACE; CHORIOCARCINOMA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NULL ALLELE; PRIORITY JOURNAL; TROPHOBLAST; AMINO ACID SEQUENCE; CELL CULTURE; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD94; BASE SEQUENCE; CHORIOCARCINOMA; CHROMIUM RADIOISOTOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RECEPTORS, IMMUNOLOGIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 11944272023     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-004-0733-7     Document Type: Article

References (34)

1. Agrawal S, Marquet J, Freeman GJ, Tawab A, Bouteiller PL, Roth P, Bolton W, Ogg G, Boumsell L, Bensussan A (1999) Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 162:1223-1226
2. Aiyar A, Leis J (1995) Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product. Biotechniques 14:366-368
3. Bainbridge DR, Ellis SA, Sargent IL (2000) The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface. J Reprod Immunol 47:1-16
4. Boucraut J, Guillaudeux T, Alizadeh M, Boretto J, Chimini G, Malecaze F, Semana G, Fauchet R, Pontarotti P, Le Bouteiller P (1993) HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR. Immunogenetics 38:117-130
5. Chapman TL, Heikeman AP, Bjorkman PJ (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11:603-613
6. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809-1818
7. Diehl M, Munz C, Keilholz W, Stevanovic S, Holmes N, Loke YW, Rammensee HG (1996) Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol 6:305-314
8. + cells by interacting with CD8. J Immunol 164:6100-6104
9. Fujii T, Ishitani A, Geraghty DE (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153:5516-5524
10. Gao GF, Willcox BE, Wyer JR, Boulter JM, O'Callaghan CA, Maenaka K, Stuart DI, Jones EY, Van Der Merwe PA, Bell JI, Jakobsen BK (2000) Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J Biol Chem 275:15232-15238
11. Geraghty DE, Koller BH, Orr HT (1987) A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 84:9145-9149
12. Hofmeister V, Weiss EH (2003) HLA-G modulates immune responses by diverse receptor interactions. Semin Cancer Biol 13:317-323
13. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C (2000) Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 183:682-688
14. Ishitani A, Geraghty DE (1992) Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 89:3947-3951
15. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG, Loke YW (1996) Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 156:2068-2076
16. Le Bouteiller P (1994) HLA class I chromosomal region, genes, and products: facts and questions. Crit Rev Immunol 14:89-129
17. Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, Rabot M, Hilgert I, Mami-Chouaib F, Tabiasco J, Boumsell L, Bensussan A (2002) Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci USA 99:16963-16968
18. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE (1995) The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591-600
19. Lenfant F, Pizzato N, Liang S, Davrinche C, Le Bouteiller P, Horuzsko A (2003) Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol 84:1-11
20. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, Lopez-Botet M (1998) HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 28:1-10
21. Lone YC, Motta I, Mottez E, Guilloux Y, Lim A, Demay F, Levraud JP, Kourilsky P, Abastado JP (1998) In vitro induction of specific cytotoxic T lymphocytes using recombinant single-chain MHC class I/peptide complexes. J Immunother 21:283-294
22. Maier S, Grzeschik M, Weiss EH, Ulbrecht M (2000) Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells. Hum Immunol 61:1059-1065
23. Mallet V, Proll J, Solier C, Aguerre-Girr M, DeRossi M, Loke YW, Lenfant F, Le Bouteiller P (2000) The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells. Hum Immunol 61:212-224
24. Moffet-King A (2002) Natural killer cells and pregnancy. Nat Rev 2:656-663
25. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, Lopez-Botet M (1999) The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 29:277-283
26. Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS (1998) HLA-G1 protein expression is not essential for fetal survival. Placenta 19:127-132
27. Onno M, Guillaudeux T, Amiot L, Renard I, Drenou B, Hirel B, Girr M, Semana G, Le Bouteiller P, Fauchet R (1994) The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum Immunol 41:79-86
28. Rajagopalan S, Fu J, Long EO (2001) Cutting edge: Induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 167:1877-1881
29. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24:406-415
30. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED (1997) The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249-5254
31. Sivori S, Parolini S, Marcenaro E, Millo R, Bottino C, Moretta A (2000) Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum Immunol 61:1055-1058
32. Ulbrecht M, Honka T, Person S, Johnson JP, Weiss EH (1992) The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 149:2945-2953
33. Ulbrecht M, Maier S, Hofmeister V, Falk CS, Brooks AG, McMaster MT, Weiss EH (2004) Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands. Hum Immunol 65:200-208
34. Ven K van der, Pfeiffer K, Skrablin S (2000) HLA-G polymorphisms and molecule function - Questions and more questions - a review. Placenta 21 [Suppl A]:S86-S92